Hirakata, Japan

Masahide Nakajima

This inventor holds 3 USPTO granted patents. Top assignees: The Green Cross Corporation, Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1996-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahide Nakajima. Retrieved from https://idiyas.com/inventor/masahide-nakajima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Masahide Nakajima

Introduction

Masahide Nakajima is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heterocyclic amide compounds. With a total of 3 patents to his name, Nakajima's inventions have the potential to impact pharmaceutical applications.

Latest Patents

Among his latest patents are "Heterocyclic amide compounds and medicinal uses thereof" and "Heterocyclic amide compounds and pharmaceutical use of the same." These patents reflect his dedication to advancing medicinal chemistry and improving therapeutic options.

Career Highlights

Throughout his career, Nakajima has worked with prominent companies such as The Green Cross Corporation and Yoshitomi Pharmaceutical Industries, Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in a collaborative environment.

Collaborations

Some of his notable coworkers include Fumihiko Akahoshi and Atsuyuki Ashimori. Their collaboration has likely contributed to the success of Nakajima's inventions and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Masahide Nakajima's work exemplifies the spirit of innovation in the field of medicinal chemistry. His patents and collaborations highlight his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…